SEOM-GECOD clinical guideline for cancer of unknown primary (update 2025)
Por:
Losa, F, Etxaniz, O, Giménez, A, Gomila, P, Iglesias, L, Longo, F, Nogales, E, Sánchez, A, Soler, G and Fernández, I
Publicada:
1 may 2026
Ahead of Print:
1 mar 2026
Resumen:
Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumors that appear as metastases for which a standard diagnostic work-up fails to identify the tissue of origin. There is now high-level evidence showing that actionable genomic alterations should be routinely determined in patients with CUP to enable molecularly guided therapy as appropriate. In this guideline (updated in 2025), we summarize diagnostic processes and therapeutic options for CUP, as well as new developments in molecular medicine that will help to improve the poor outcomes associated with this unique disease entity.
Filiaciones:
Losa, F:
ICO Hospitalet, Hosp St Joan Despi Moises Broggi, Barcelona, Spain
:
Hosp Germans Trias i Pujol, ICO Badalona, Barcelona, Spain
Giménez, A:
Hosp Lluis Alcanys Xativa, Valencia, Spain
Gomila, P:
Hosp Miguel Servet Zaragoza, Zaragoza, Spain
Iglesias, L:
Hosp Univ 12 Octubre, Madrid, Spain
Longo, F:
Hosp Univ Ramon y Cajal, IRYCIS, CIBERONC, Madrid, Spain
Nogales, E:
Hosp Univ Virgen Macarena, Seville, Spain
Sánchez, A:
Hosp Univ Puerta Hierro, Majadahonda, Madrid, Spain
Soler, G:
Hosp Germans Trias i Pujol, Hosp Mataro, ICO Badalona, Barcelona, Spain
Fernández, I:
Hosp Alvaro Cunqueiro, IIGS, Vigo, Spain
Green Submitted, hybrid
|